Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2.
暂无分享,去创建一个
Adam J Kuszak | Nils G Walter | R. Sunahara | N. Walter | H. Mosberg | A. Kuszak | Sethuramasundaram Pitchiaya | Jessica P Anand | Henry I Mosberg | Roger K Sunahara | Jessica P. Anand | S. Pitchiaya
[1] T. Huber,et al. Rapid incorporation of functional rhodopsin into nanoscale apolipoprotein bound bilayer (NABB) particles. , 2008, Journal of molecular biology.
[2] A. Engel,et al. Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.
[3] J. Traynor,et al. Comparison of the Relative Efficacy and Potency of μ-Opioid Agonists to Activate Gαi/o Proteins Containing a Pertussis Toxin-Insensitive Mutation , 2006, Journal of Pharmacology and Experimental Therapeutics.
[4] J T Williams,et al. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[5] H. Akil,et al. Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor. , 1998, The Journal of pharmacology and experimental therapeutics.
[6] W. Schaffner,et al. A rapid, sensitive, and specific method for the determination of protein in dilute solution. , 1973, Analytical biochemistry.
[7] H. Loh,et al. Isolation and purification of morphine receptor by affinity chromatography. , 1985, Life sciences.
[8] A. Milon,et al. Green fluorescent protein as a reporter of human μ-opioid receptor overexpression and localization in the methylotrophic yeast Pichia pastoris , 2002 .
[9] S. Sligar,et al. Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. , 2007, Biochemistry.
[10] Krzysztof Palczewski,et al. Efficient Coupling of Transducin to Monomeric Rhodopsin in a Phospholipid Bilayer* , 2008, Journal of Biological Chemistry.
[11] Graeme Milligan,et al. G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.
[12] R. Stevens,et al. GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.
[13] H. Akil,et al. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. , 1996, The Journal of pharmacology and experimental therapeutics.
[14] T. Costa,et al. Guanine nucleotide-mediated inhibition of opioid agonist binding. Modulatory effects of ions and of receptor occupancy. , 1989, Biochemical pharmacology.
[15] P. Prather,et al. Interaction of Co-Expressed μ- and δ-Opioid Receptors in Transfected Rat Pituitary GH3 Cells , 2001 .
[16] R. Schulz,et al. Expression of μ-, δ- and κ-opioid receptors in baculovirus-infected insect cells , 1996 .
[17] A. Milon,et al. Expression and pharmacological characterization of the human μ‐opioid receptor in the methylotrophic yeast Pichia pastoris , 1996, FEBS letters.
[18] T. S. Kobilka,et al. Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. , 1992, The Journal of biological chemistry.
[19] L. Devi,et al. Oligomerization of opioid receptors. , 2002, Methods.
[20] J. Meunier,et al. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at μ- and κ-opioid receptor sites in rabbit and guinea-pig cerebellum membranes , 1985 .
[21] D. Oprian,et al. Transducin Activation by Nanoscale Lipid Bilayers Containing One and Two Rhodopsins* , 2007, Journal of Biological Chemistry.
[22] P. Garriga,et al. Effect of dodecyl maltoside detergent on rhodopsin stability and function , 2003, Vision Research.
[23] E. Barnard,et al. Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[24] B. O'dowd,et al. Oligomerization of opioid receptors: generation of novel signaling units. , 2002, Current opinion in pharmacology.
[25] Xiaochun Sun,et al. Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer , 2005, Molecular Pharmacology.
[26] Richard N. Zare,et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.
[27] Alain Milon,et al. Optimizing functional versus total expression of the human mu-opioid receptor in Pichia pastoris. , 2002, Protein expression and purification.
[28] S. Salvadori,et al. Synthesis and receptor binding analysis of dermorphin hepta-, hexa- and pentapeptide analogues. Evidence for one- and two-side binding models for the mu-opioid receptor. , 2009, International journal of peptide and protein research.
[29] Lakshmi A. Devi,et al. Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.
[30] B. O'dowd,et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.
[31] S. Sligar,et al. Functional reconstitution of Beta2-adrenergic receptors utilizing self-assembling Nanodisc technology. , 2006, BioTechniques.
[32] F. Simonin,et al. Characterization of delta, kappa, and mu human opioid receptors overexpressed in baculovirus-infected insect cells. , 1997, The Journal of biological chemistry.
[33] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[34] Krzysztof Palczewski,et al. Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.
[35] Lakshmi A. Devi,et al. G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.
[36] B. Monsarrat,et al. Solubilization, purification, and mass spectrometry analysis of the human mu-opioid receptor expressed in Pichia pastoris. , 2005, Protein expression and purification.
[37] A. Blume,et al. Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[38] D. Ballou,et al. The use of protocatechuate dioxygenase for maintaining anaerobic conditions in biochemical experiments. , 2000, Analytical biochemistry.
[39] W. Watkins,et al. Purification of opioid receptor in the presence of sodium ions. , 1992, Life sciences.
[40] T. Kenakin. Principles: receptor theory in pharmacology. , 2004, Trends in pharmacological sciences.
[41] B. Cox,et al. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes. , 1988, Molecular pharmacology.
[42] E. J. Simon,et al. Purification of an active opioid-binding protein from bovine striatum. , 1985, The Journal of biological chemistry.
[43] A. Engel,et al. Functional and Structural Characterization of Rhodopsin Oligomers* , 2006, Journal of Biological Chemistry.
[44] Mei Bai,et al. Dimerization of G-protein-coupled receptors: roles in signal transduction. , 2004, Cellular signalling.